Carcinoma, Squamous Cell: all 1,779 studies
Page 13 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT03387904Phase 2
- An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and NeckWithdrawnNCT03386838Phase 3
- IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell CarcinomaCompletedNCT03381183Phase 1
- Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal CancerStatus unknownNCT03377400Phase 2
- Recurrence in Buccinator Muscle Excision With the Skin Versus Without the Skin in Buccal Squamous Cell CarcinomaStatus unknownNCT03364166Not applicable
- Local Control After Robot-assisted Supraglottic LaryngectomyCompletedNCT03357107
- A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based TherapyStatus unknownNCT03356587Phase 2
- Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)CompletedNCT03353077Not applicable
- Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic StudyStatus unknownNCT03345966Not applicable
- Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)WithdrawnNCT03342352Phase 3
- Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or MelanomaCompletedNCT03336606Phase 1
- Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)TerminatedNCT03333694Phase 1
- Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective StudyCompletedNCT03325738
- Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT03325465Phase 2
- EPR Tumor Oximetry With CE India InkTerminatedNCT03321903
- Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the LungTerminatedNCT03321747Phase 1
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell CarcinomaActive, not recruitingNCT03306901Not applicable
- The Oral Microbiome and Upper Aerodigestive Squamous Cell CancerCompletedNCT03304132
- Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell LineCompletedNCT03292822Phase 1
- Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCStatus unknownNCT03291002Phase 1
- Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell LineStatus unknownNCT03288298Early Phase 1
- Immunotherapy and SBRT for Metastatic Head and Neck CarcinomasCompletedNCT03283605Phase 1/2
- Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck CancerCompletedNCT03281499Not applicable
- A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCCTerminatedNCT03276819Not applicable
- Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT03274011Phase 2
- A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT03267121Phase 2
- Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell CarcinomaTerminatedNCT03251417Phase 2
- Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SDTerminatedNCT03246685Phase 2
- Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT03238365Early Phase 1
- Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin ChemoradiationCompletedNCT03225157
- Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentStatus unknownNCT03224221Phase 2
- PEN-866 in Patients With Advanced Solid MalignanciesStatus unknownNCT03221400Phase 1/2
- A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic CancerCompletedNCT03212469Phase 1/2
- NCI UNC Project ESCCTerminatedNCT03206125
- Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionCompletedNCT03202992Phase 1
- The Diagnosis of NPC Using the Probe-based Confocal Laser EndomicroscopyStatus unknownNCT03202173Not applicable
- Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT03200691Phase 2
- An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)CompletedNCT03198130Phase 1
- Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.Status unknownNCT03196843Phase 4
- Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03193424Phase 2
- Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal CancerCompletedNCT03187314Phase 2
- Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive SystemStatus unknownNCT03185988Phase 2
- Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell CancerCompletedNCT03182959Early Phase 1
- Impact of Ribociclib on Head and Neck Squamous Cell CancerTerminatedNCT03179956Early Phase 1
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
- PET/MRI in Oropharyngeal Squamous Cell Carcinoma EvaluationStatus unknownNCT03163797
- Role of Myostatin, Activin A and Follistatin Cachexia of ENT CancersCompletedNCT03162042
- Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in MexicoWithdrawnNCT03161613
- Functional ImaGing of Heterogeneity in Head and Neck Tumors - Validation From Surgical SpecimensCompletedNCT03160495
- HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in MalawiCompletedNCT03160209
- Saliva-based Detection of CD44CompletedNCT03148665
- Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell CancerCompletedNCT03144778Phase 1
- Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT03129061Phase 1
- Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03126708Phase 2
- Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+Status unknownNCT03121313Phase 2
- Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHNStatus unknownNCT03117257Phase 2
- Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)WithdrawnNCT03114280Phase 1/2
- Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based TherapyCompletedNCT03114163
- Hepatitis C Virus Detection in Oral Squamous Cell CarcinomaCompletedNCT03109457
- NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT03109158Phase 1/2
- A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownNCT03096184Phase 2
- Biomarker-based Study in R/M SCCHNActive, not recruitingNCT03088059Phase 2
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- CTC Detection Rate in SCCHN With a in Vivo DeviceStatus unknownNCT03071900Not applicable
- Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-ScopeStatus unknownNCT03069846Not applicable
- Immune Response Evaluation to Curative Conventional TherapyStatus unknownNCT03053661
- WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck CancerCompletedNCT03028766Phase 1
- Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in SituStatus unknownNCT03025724Not applicable
- Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell CarcinomaActive, not recruitingNCT03024489Phase 1/2
- A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).CompletedNCT03022409Phase 1
- Alpha Radiation Emitters Device for the Treatment of Squamous Cell CarcinomaCompletedNCT03015883Not applicable
- Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCCCompletedNCT03001596Not applicable
- A Study of SBRT for OligoMetastatic ESCCCompletedNCT03000816Not applicable
- Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCCCompletedNCT02999646Not applicable
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryCompletedNCT02997553Phase 3
- Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02993991Phase 1
- Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral TongueStatus unknownNCT02985255Phase 2
- A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.CompletedNCT02976987Phase 2
- Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell CarcinomaCompletedNCT02976909Phase 2
- Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentCompletedNCT02976896Phase 2
- Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT02969473Phase 2
- Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT02964455Phase 1
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Quantitative Optical Sensor Findings in Head & Neck Squamous Cell CarcinomaStatus unknownNCT02943044
- Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)CompletedNCT02938273Phase 1
- Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity CancerCompletedNCT02923258Phase 2/3
- Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT02916511Phase 2
- The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell CarcinomaStatus unknownNCT02916368
- A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell CarcinomaStatus unknownNCT02915965Phase 2
- The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCStatus unknownNCT02915432Phase 1/2
- S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell CarcinomaStatus unknownNCT02913066Phase 2
- Long-term Outcomes of Superficial Esophageal Squamous Cell CarcinomaStatus unknownNCT02908204
- Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinCompletedNCT02883556Phase 2
- Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.CompletedNCT02882308Phase 2
- Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck CancerCompletedNCT02879968
- Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell CarcinomaStatus unknownNCT02876978Phase 1
- Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral CavityCompletedNCT02873819Phase 2
- Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) OperableCompletedNCT02855723Not applicable
- One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell CarcinomaCompletedNCT02852343